ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2025

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

A Fernandez-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.